Literature DB >> 35085929

Predictors of suicidal ideation trajectories in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study.

Bartholt Bloomfield-Clagett1, Dede K Greenstein1, Joseph M Kush2, Rashelle Musci2, Carlos A Zarate1, Elizabeth D Ballard3.   

Abstract

A better understanding of suicidal ideation (SI), including patterns of SI, may help elucidate links between depression, SI, and suicidal behavior. This study sought to identify trajectories of SI in a large, community-based clinical trial of participants with major depressive disorder (MDD) and to investigate the relationships between these trajectories and predictors of interest, including anxiety and anhedonia. A longitudinal latent class analysis was conducted in 3923 participants enrolled in Level 1 of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study of citalopram for the treatment of MDD. An unconditional latent class analysis was conducted using SI at study weeks 0, 2, 4, 6, and 9 as the indicators. A multinomial regression was then conducted with SI trajectory as the outcome and anhedonia, severity of depressive symptoms, atypical depression, anxiety, history of suicide attempt, history of substance abuse, history of trauma, and other covariates as the predictors. Four SI trajectories were identified: 1) variable SI; 2) little-to-no SI; 3) persistent SI; and 4) improving SI. Compared to the little-to-no SI trajectory, those with more severe anhedonia were more likely to experience persistent SI, while those with more severe anxiety were more likely to experience improving SI. Factors that distinguish SI trajectories, such as anxiety and anhedonia, may be critical targets for intervention or profiles for prognosis.
Copyright © 2022. Published by Elsevier Ltd.

Entities:  

Keywords:  Anhedonia; Anxiety; Clinical trial; Depression; Suicidal ideation; Suicide

Mesh:

Year:  2022        PMID: 35085929      PMCID: PMC8961701          DOI: 10.1016/j.jpsychires.2022.01.027

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  28 in total

1.  Variability in suicidal ideation: a better predictor of suicide attempts than intensity or duration of ideation?

Authors:  Tracy K Witte; Kathleen K Fitzpatrick; Thomas E Joiner; Norman Bradley Schmidt
Journal:  J Affect Disord       Date:  2005-10       Impact factor: 4.839

2.  Assessing interpersonal and mood factors to predict trajectories of suicidal ideation within an inpatient setting.

Authors:  Michael J Kyron; Geoff R Hooke; Andrew C Page
Journal:  J Affect Disord       Date:  2019-04-08       Impact factor: 4.839

3.  Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D.

Authors:  Jon S Novick; Jonathan W Stewart; Stephen R Wisniewski; Ian A Cook; Radmila Manev; Andrew A Nierenberg; Jerrold F Rosenbaum; Kathy Shores-Wilson; G K Balasubramani; Melanie M Biggs; Sid Zisook; A John Rush
Journal:  J Clin Psychiatry       Date:  2005-08       Impact factor: 4.384

4.  An interactive model of anxiety sensitivity relevant to suicide attempt history and future suicidal ideation.

Authors:  Daniel W Capron; Jesse R Cougle; Jessica D Ribeiro; Thomas E Joiner; Norman B Schmidt
Journal:  J Psychiatr Res       Date:  2011-11-04       Impact factor: 4.791

5.  Anxiety disorders and risk for suicidal ideation and suicide attempts: a population-based longitudinal study of adults.

Authors:  Jitender Sareen; Brian J Cox; Tracie O Afifi; Ron de Graaf; Gordon J G Asmundson; Margreet ten Have; Murray B Stein
Journal:  Arch Gen Psychiatry       Date:  2005-11

6.  Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study.

Authors:  Sidney Zisook; Madhukar H Trivedi; Diane Warden; Barry Lebowitz; Michael E Thase; Jonathan W Stewart; Christine Moutier; Maurizio Fava; Stephen R Wisniewski; James Luther; A John Rush
Journal:  J Affect Disord       Date:  2009-02-14       Impact factor: 4.839

7.  The impact of medical comorbidity on acute treatment in major depressive disorder.

Authors:  Dan V Iosifescu; Andrew A Nierenberg; Jonathan E Alpert; Megan Smith; Stella Bitran; Christina Dording; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2003-12       Impact factor: 18.112

8.  Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression.

Authors:  Thomas E Schlaepfer; Michael X Cohen; Caroline Frick; Markus Kosel; Daniela Brodesser; Nikolai Axmacher; Alexius Young Joe; Martina Kreft; Doris Lenartz; Volker Sturm
Journal:  Neuropsychopharmacology       Date:  2007-04-11       Impact factor: 7.853

9.  Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression.

Authors:  N Lally; A C Nugent; D A Luckenbaugh; R Ameli; J P Roiser; C A Zarate
Journal:  Transl Psychiatry       Date:  2014-10-14       Impact factor: 6.222

Review 10.  Epidemiology of Suicide and the Psychiatric Perspective.

Authors:  Silke Bachmann
Journal:  Int J Environ Res Public Health       Date:  2018-07-06       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.